CORONNELLO, MARCELLA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.218
EU - Europa 4.180
AS - Asia 2.647
SA - Sud America 274
Continente sconosciuto - Info sul continente non disponibili 90
OC - Oceania 57
AF - Africa 48
AN - Antartide 1
Totale 13.515
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.137
RU - Federazione Russa 1.281
PL - Polonia 842
SG - Singapore 789
IT - Italia 734
CN - Cina 702
IE - Irlanda 399
HK - Hong Kong 395
SE - Svezia 309
KR - Corea 233
VN - Vietnam 229
BR - Brasile 213
DE - Germania 146
FI - Finlandia 113
UA - Ucraina 109
FR - Francia 98
IN - India 97
GB - Regno Unito 64
CA - Canada 59
AU - Australia 50
JP - Giappone 45
JO - Giordania 29
CH - Svizzera 23
BD - Bangladesh 22
TR - Turchia 21
ID - Indonesia 20
AR - Argentina 18
NL - Olanda 18
EC - Ecuador 16
ES - Italia 16
IQ - Iraq 12
CI - Costa d'Avorio 11
MX - Messico 10
CO - Colombia 8
SA - Arabia Saudita 8
CR - Costa Rica 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
CL - Cile 6
NG - Nigeria 6
NZ - Nuova Zelanda 6
PH - Filippine 6
ZA - Sudafrica 6
MA - Marocco 5
PY - Paraguay 5
VE - Venezuela 5
BJ - Benin 4
LT - Lituania 4
PK - Pakistan 4
TN - Tunisia 4
CY - Cipro 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
MY - Malesia 3
NP - Nepal 3
UZ - Uzbekistan 3
AT - Austria 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
DK - Danimarca 2
EU - Europa 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
LV - Lettonia 2
MU - Mauritius 2
OM - Oman 2
SC - Seychelles 2
TH - Thailandia 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
BH - Bahrain 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CG - Congo 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GR - Grecia 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MK - Macedonia 1
NI - Nicaragua 1
PG - Papua Nuova Guinea 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SX - ???statistics.table.value.countryCode.SX??? 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.430
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.458
Warsaw 841
Ashburn 574
Singapore 535
Dublin 398
Fairfield 393
Chandler 329
Hong Kong 316
Seoul 230
San Jose 217
Cambridge 194
Woodbridge 181
Houston 170
Jacksonville 168
Beijing 166
Seattle 161
Hefei 153
Milan 130
Wilmington 122
Council Bluffs 117
Florence 98
Buffalo 91
Ho Chi Minh City 78
Ann Arbor 77
Princeton 76
Lauterbourg 70
Los Angeles 66
Mumbai 65
Boston 61
The Dalles 58
Altamura 53
Boardman 51
Lawrence 51
Moscow 50
Rome 49
Dallas 48
Melbourne 48
Munich 47
Phoenix 46
Shanghai 46
Tokyo 44
Hanoi 39
Helsinki 36
New York 35
Naples 24
Bern 23
Medford 22
Turin 22
San Diego 21
Kent 20
Redondo Beach 20
Dearborn 19
São Paulo 18
Toronto 17
Chicago 16
Columbus 16
Jakarta 15
Dong Ket 14
Turku 14
Bologna 12
Clifton 12
Guangzhou 12
Abidjan 11
Atlanta 11
Figino 11
London 11
Rio de Janeiro 11
Norwalk 10
Orem 10
West Jordan 10
Bari 9
Bengaluru 9
Chennai 9
Haiphong 9
Paris 9
Quito 9
San Francisco 9
Tianjin 9
Andover 8
Brooklyn 8
Da Nang 8
Denver 8
Genoa 8
Izmir 8
Palermo 8
Yubileyny 8
Frankfurt am Main 7
Hillsboro 7
Montreal 7
Bremen 6
Brussels 6
Cagliari 6
Falls Church 6
Giugliano in Campania 6
Miano 6
Poplar 6
San José 6
Abuja 5
Baghdad 5
Barcelona 5
Totale 8.858
Salva come PNG Salva come JPEG
Nome #
MECHANISMS OF CYTOTOXICITY OF SELECTED ORGANOGOLD(III) COMPOUNDS 399
Cytotoxic activity of 3-nitropyrazolo[5,1-c][1,2,4]benzotriazine derivatives: a new series of anti-proliferative agents. 372
Solution Chemistry and Cytotoxic Properties of Novel Organogold(III) Compounds 353
Immunophenotypical markers, ultrastructure and chemosensitivity profile of metastatic melanoma cells. 343
Development and characterization of an in vitro model of colorectal adenocarcinoma with MDR phenotype 343
Enhanced Efficacy of Artemisinin Loaded in Transferrin-Conjugated Liposomes versus Stealth Liposomes against HCT-8 Colon Cancer Cells 338
Pirenoxine prevents oxidative effects of argon fluoride excimer laser irradiation in rabbit corneas: biochemical, histological and cytofluorimetric evaluations. 280
Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug-resistance (MDR) modulators 255
Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl esters 234
Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents 229
N,N-bis(cyclohexanol)amine aryl esters: a new class of highly potent Pgp-dependent multidrug resistance (MDR) inhibitors 227
Dual P-glycoprotein and CA XII inhibitors: A new strategy to reverse the P-gp Mediated Multidrug Resistance (MDR) in cancer cells y 215
New structure–activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR) 214
LIPOSOMES LOADED WITH BERBERINE HYDROCHLORIDE: DEVELOPMENT, OPTIMISATION AND IN VITRO CITOTOXICITY 213
A novel inward-rectifying K+ current with a cell-cycle dependence governs the resting potential of mammalian neuroblastoma cells. 208
Aminoarylesters as multidrug resistance (MDR) reverting agents endowed with high potency and efficacy 205
Design and synthesis of aminoester heterodimers containing flavone or chromone moieties as modulators of P-glycoprotein-based multidrug resistance (MDR) 196
N,N-bis(alkanol)amine aryl esters and N,N-bis(cyclohexanol)amine aryl esters: Idantification of a new class of Pgp-dependent multidrug resistance (MDR) reverters andowed with potencies in the nanomolar range 189
New dual P-Glycoprotein (P-gp) and human carbonic anhydrase XII (hCA XII) inhibitors as Multidrug Resistance (MDR) reversers in cancer cells 186
N-alkanol-N-cyclohexanol amine aryl esters: Multidrug resistance (MDR) reversing agents with high potency and efficacy 184
Chromosomal characterization of methotrexate-resistant human T-lymphoblast leukemia cells (CCRF-CEM) with impaired polyglutamylation. 184
P-glycoprotein and carbonic anhydrases hybrid inhibitors: a new strategy to reverse multidrug resistance (MDR) in cancer cells 182
Inhibitory effect of luteinising hormone-releasing hormone analogues on human endometrial cancer in vitro. 179
Establishment and characterization of a new spontaneously immortalized ER-/PR-/HER2+ human breast cancer cell line, DHSF-BR16 177
Cytotoxicity, DNA damage, and cell cycle perturbations induced by two representative gold(III) complexes in human leukemic cells with different cisplatin sensitivity 176
Co-Delivery of Berberine Chloride and Tariquidar in Nanoliposomes Enhanced Intracellular Berberine Chloride in a Doxorubicin-Resistant K562 Cell Line Due to P-gp Overexpression 175
Melatonin's growth-inhibitory effect on hepatoma AH 130 in the rat. 172
Alkaline elution of DNA as a method for assessing genotoxic effects of drugs: its application to a series of antiviral compounds. 169
Strategy to provide a useful solution to effective delivery of dihydroartemisinin: development, characterization and in vitro studies of liposomal formulations 169
Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues. 164
Gold(III) Complexes with Bipyridyl Ligands: Solution Chemistry, Cytotoxicity and DNA Binding Properties 160
Induction of differentiation of HL-60 cells along the monocytic pathway by 5-methyltetrahydrofolate. 158
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 156
Structural and Solution Chemistry, Antiproliferative Effects, and DNA and Protein Binding Properties of a Series of Dinuclear Gold(III) Compounds with Bipyridyl Ligands 156
Analisi cariologica di linee cellulari leucemiche umane CCRF-CEM resistenti al metotressato (MTX) per alterata poliglutammilazione. 153
New multidrug resistance (MDR) agents endowed with good potency and efficacy 152
Clinical chemotherapeutic evaluation of fosfomycin plus amoxicillin (co-fosfolactamine): a prospective double-blind clinical trial. 152
Biochemical modulation of fluoropyrimidines by antifolates and folates in an in vitro model of human leukemia. 151
New dendrimer-based nanoparticles enhance solubility of curcumin. 150
Role of ATP-binding cassette transporters in cancer initiation and progression 149
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 147
Efficacy of 3-(p-fluorofenyl)-L-alanyl-3-m-bis(2-chloroethyl)amino-phenyl-L-methionine ethoxy HCl (PTT-119) on human leukemia cell lines 147
Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cells. 146
Enhancement of fluoropyrimidine cytotoxicity by 5-methyltetrahydrofolate in a human leukemia cell line, CCRF-CEM. 146
Transferrin-targeted stealth liposomes loaded with artemisinin: The Trojan horse to enhance its selectivity and anticancer activity 146
Synthesis of new pyrazolo[5,1-c][1,2,4]benzotriazines, pyrazolo[5,1-c]pyrido[4,3-e][1,2,4]triazines and their open analogues as cytotoxic agents in normoxic and hypoxic conditions. 146
Effect of the l and d stereoisomers of 5-formyltetrahydrofolate (LV) and 5-methytetrahydrofolate (5-CH3-H4PteGlu) on fluoropyrimidine cytotoxicity in human leukemic CCRF-CEM cells 140
Bacteriological, pharmacokinetic and clinical study of dibekacin 138
Enhancement of fluoropyrimidine cytotoxicity by 5-methyltetrahydrofolate in a human leukemia cell line, CCRF-CEM 135
Modulation of fluoropyrimidine cytotoxicity by methotrexate or5-methyltetrahydrofolate in human leukemia cells in vitro 135
Structure-activity relationships studies in a series of N,N-bis(alkanol)amine aryl esters as P-glycoprotein (Pgp) dependent multidrug resistance (MDR) inhibitors 135
Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotides. 133
Conventional, stealth and transferrin-conjiugates liposomes for artemisinin delivery to cancer cells. 132
Citotossicità comparativa di metotrexato (MTX) e trimetrexato (TMTX) in cellule leucemiche umane. 131
Liposomes for dihydroartemisinin delivery to cancer cells: development, characterization and in vitro studies. 129
Gold(III) complexes as potential antitumor agents: cytotoxic properties and interaction with DNA of some selected gold(III) compounds 129
Inhibition of MDR1 gene expression by antimessenger oligonucleotides lowers multiple drug resistance 125
In vitro effects of brodimoprim on human polymorphonuclear leukocyte functions. Preliminary results 123
Compa¬rative effects of two non-classical antifolates, tri¬metrexate (TMQ) and triazinate (TZT), on 5-fluoroura¬cil (FUra) cytotoxicity against human CCRF-CEM leukemia cells. 122
Citotossicità comparativa del 3-(p-fluorofenil)-L-alanilmetionina etilestere clori¬drato, PTT-119, e del melfalan (L-PAM) in cellule tu¬morali umane. 121
Efficacy of 3-(p-fluorofenyl)-L-alanyl-3-m-bis(2-chloroethyl)amino-phenyl-L-methionine ethoxy HCl (PTT-119) on human leukemia cell lines 119
Solution chemistry and DNA binding properties of cytotoxic gold(III) complexes. 119
Characterization and selective pharmacologic circumven¬tion of metho¬trexate (MTX) resi¬stance in leukemia cells 118
Impaired methotrexate polyglutamylation in a human leukemia cell line resistant to short-term, high-dose methotrexate. 116
Unexpected Multidrug Resistance (MDR) reverting activity of a new series of N,N-bis(arylalkanol)amine aryl esters 116
Isomeric N,N-dicyclohexane-4-ol-amine aryl esters: chemical and pharmacological development of highly potent and efficacious Pgp-dependent MDR inhibitors 116
Multidrug Resistance (MDR) reverting agents:structure-activity relationships of a series of N,Nbis(arylalkanol)amine aryl esters 113
Synthesis of functionalised organochalcogenides and in vitro evaluation of their antioxidant activity 112
Pharmacokinetics of 5-methyltetrahydrofolate in normal adults 111
Sviluppo di linee cellulari leu¬cemiche umane resistenti al metotres¬sato (MTX). Ri¬sultati preliminari con un modello in studio in vitro alternativo 108
Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug. 107
Effetti di esposizioni alter¬nate a trimetressato (TMTX) e metotres¬sato (MTX) sulla insorgenza di resistenza agli antifolici in un modello di leucemia T-linfoblastica umana (CCRF-CEM) in vitro. 107
Bacteriological, pharmacokinetic and clinical evaluation of bekanamycin 106
Modulazione dei livelli di mRNA della diidrofolico reduttasi mediante oligonucleotidi antisenso in cellule leucemiche umane (CCRF-CEM/E) con superespressione di questo enzima. 101
Valutazione dell'indice terapeu¬tico in vi¬tro di un vettore liposomiale veicolante metotrexato (MTX) in cellule leucemiche umane CCRF-CEM in immu¬nociti umani nor¬mali. 93
Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 90
Modulation of fluorodeoxyuridine cytotoxicity in human adenocarcinoma HCT-8 cells by antisense oligonucleotides targeted to thymidylate synthase. 88
Modulation of dihydrofolate reductase (DHFR) mRNA levels in human leukemia CCRF-CEM/E line overexpressing this enzyme by antisense oligodeoxynucleotides. 80
Polyglutamylation: an essential step in the activation of 5,10-dideazatetrahydrofolic acid (DDATHF) 80
Flow cy¬tometric evaluation of the in¬hibitory effects of li¬posome-entrapped methotrexate (MTX) on lymphocyte proliferation and polymorphonuclear (PMN) leukocyte functions. 79
Modulation of fluorodeoxyuridine cytotoxicity in human adenocarcinoma HCT-8 cells by antisense oligonucleotides targeted to thymidylate synthase. 73
In vitro effects of brodimoprim on human polymorphonuclear leukocyte functions. Preliminary results 73
Ultrastructural and chemosensitivity features of primary metastatic melanoma cells: preliminary results. 65
null 52
Totale 13.515
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.912
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.912
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022436 0 0 29 33 18 16 14 33 22 16 129 126
2022/20231.430 133 183 89 100 126 273 204 87 151 13 32 39
2023/2024567 25 60 90 25 32 120 25 116 9 28 20 17
2024/20253.748 142 380 210 540 1.121 639 46 155 177 61 132 145
2025/20263.699 458 546 351 245 420 139 397 188 210 192 88 465
2026/2027688 122 300 266 0 0 0 0 0 0 0 0 0
Totale 13.515